Ewa Ehrenborg
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet, Metabolism, and Disease
- Biochemistry top 1%
- Lipid metabolism and biosynthesis
Papers in
-
- Peroxisome Proliferator-Activated Receptors 23
- Metabolism, Diabetes, and Cancer 13
-
- Growth Hormone and Insulin-like Growth Factors 14
- Diabetes, Cardiovascular Risks, and Lipoproteins 11
- Co-authors
- Anders Hamsten (21 shared papers)Anna Krook (3 shared papers)Katja Kannisto (11 shared papers)Josefin Skogsberg (11 shared papers)Fredrik Karpe (11 shared papers)Per Eriksson (13 shared papers)Hannele Yki‐Järvinen (9 shared papers)Rachel M. Fisher (8 shared papers)
- Journals
- Circulation (5 papers)Journal of Lipid Research (5 papers)International Journal of Molecular Medicine (5 papers)Arteriosclerosis Thrombosis and Vascular Biology (5 papers)Atherosclerosis (4 papers)
- Partner nations
- SwedenUnited KingdomFinland
In The Last Decade
Ewa Ehrenborg
82 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 120
- Endocrinology, Diabetes and Metabolism 932
- Biochemistry 349
- Cardiology and Cardiovascular Medicine 724
- Physiology 811
- Cancer Research 468
Countries citing papers authored by Ewa Ehrenborg
This map shows the geographic impact of Ewa Ehrenborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Ehrenborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Ehrenborg more than expected).
Fields of papers citing papers by Ewa Ehrenborg
This network shows the impact of papers produced by Ewa Ehrenborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Ehrenborg. The network helps show where Ewa Ehrenborg may publish in the future.
Co-authors
The 25 scholars most cited alongside Ewa Ehrenborg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 236 | |
| 2 | 2004 | 172 | |
| 3 | 2009 | 172 | |
| 4 | 2004 | 149 | |
| 5 | 2016 | 124 | |
| 6 | 1998 | 115 | |
| 7 | 2003 | 114 | |
| 8 | 2005 | 113 | |
| 9 | 2003 | 106 | |
| 10 | 1999 | 103 | |
| 11 | 2005 | 100 | |
| 12 | 2003 | 98 | |
| 13 | 2009 | 96 | |
| 14 | 2013 | 73 | |
| 15 | 2003 | 68 | |
| 16 | 2002 | 68 | |
| 17 | 2003 | 65 | |
| 18 | 2009 | 60 | |
| 19 | 2006 | 59 | |
| 20 | 2004 | 55 |
About Ewa Ehrenborg
Ewa Ehrenborg is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Physiology and Cancer Research, having authored 84 papers that have together received 3.4k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (23 papers), Adipose Tissue and Metabolism (17 papers), Growth Hormone and Insulin-like Growth Factors (14 papers), Metabolism, Diabetes, and Cancer (13 papers), Cancer, Lipids, and Metabolism (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Lipid metabolism and disorders (11 papers) and Lipid metabolism and biosynthesis (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (932 citations), Biochemistry (349 citations), Cardiology and Cardiovascular Medicine (724 citations), Physiology (811 citations) and Cancer Research (468 citations). Ewa Ehrenborg has collaborated with scholars based in Sweden, United Kingdom and Finland. Frequent co-authors include Anders Hamsten, Anna Krook, Katja Kannisto, Josefin Skogsberg, Fredrik Karpe, Per Eriksson, Hannele Yki‐Järvinen, Rachel M. Fisher, Per Tornvall and Kirsi H. Pietiläinen. Their work appears in journals such as Circulation, Journal of Lipid Research, International Journal of Molecular Medicine, Arteriosclerosis Thrombosis and Vascular Biology and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.